vs
Elevance Health(ELV)与Meta Platforms(META)财务数据对比。点击上方公司名可切换其他公司
Meta Platforms的季度营收约是Elevance Health的1.2倍($59.9B vs $49.7B),Meta Platforms净利率更高(38.0% vs 1.1%,领先36.9%),Meta Platforms同比增速更快(23.8% vs 1.8%),过去两年Meta Platforms的营收复合增速更高(28.2% vs 6.5%)
Elevance Health是美国知名健康保险公司,2022年6月前名为Anthem, Inc.。按营收规模计算,该公司是全球第七大医疗保健企业,通过Anthem蓝十字蓝盾、加州Anthem蓝十字、Wellpoint、Carelon等附属机构,提供医疗、医药、牙科、精神健康、长期护理、残疾保险等多元服务。
Meta Platforms是总部位于美国加利福尼亚州门洛帕克的跨国科技巨头,属于全球头部科技企业阵营。旗下运营Facebook、Instagram、WhatsApp、Messenger、Threads等多款知名社交媒体及通讯服务,同时开展自有及第三方站点广告业务,2023年广告收入占其总营收的97.8%。
ELV vs META — 直观对比
营收规模更大
META
是对方的1.2倍
$49.7B
营收增速更快
META
高出22.0%
1.8%
净利率更高
META
高出36.9%
1.1%
两年增速更快
META
近两年复合增速
6.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $49.7B | $59.9B |
| 净利润 | $547.0M | $22.8B |
| 毛利率 | 88.9% | 81.8% |
| 营业利润率 | 0.6% | 41.3% |
| 净利率 | 1.1% | 38.0% |
| 营收同比 | 1.8% | 23.8% |
| 净利润同比 | -74.9% | 9.3% |
| 每股收益(稀释后) | $2.56 | $8.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ELV
META
| Q1 26 | $49.7B | — | ||
| Q4 25 | $49.7B | $59.9B | ||
| Q3 25 | $50.7B | $51.2B | ||
| Q2 25 | $49.8B | $47.5B | ||
| Q1 25 | $48.9B | $42.3B | ||
| Q4 24 | $45.4B | $48.4B | ||
| Q3 24 | $45.1B | $40.6B | ||
| Q2 24 | $43.9B | $39.1B |
净利润
ELV
META
| Q1 26 | $547.0M | — | ||
| Q4 25 | $547.0M | $22.8B | ||
| Q3 25 | $1.2B | $2.7B | ||
| Q2 25 | $1.7B | $18.3B | ||
| Q1 25 | $2.2B | $16.6B | ||
| Q4 24 | $418.0M | $20.8B | ||
| Q3 24 | $1.0B | $15.7B | ||
| Q2 24 | $2.3B | $13.5B |
毛利率
ELV
META
| Q1 26 | 88.9% | — | ||
| Q4 25 | 88.9% | 81.8% | ||
| Q3 25 | 89.4% | 82.0% | ||
| Q2 25 | 89.4% | 82.1% | ||
| Q1 25 | 89.8% | 82.1% | ||
| Q4 24 | 86.8% | 81.7% | ||
| Q3 24 | 88.7% | 81.8% | ||
| Q2 24 | 89.0% | 81.3% |
营业利润率
ELV
META
| Q1 26 | 0.6% | — | ||
| Q4 25 | 0.6% | 41.3% | ||
| Q3 25 | 2.6% | 40.1% | ||
| Q2 25 | 4.9% | 43.0% | ||
| Q1 25 | 6.5% | 41.5% | ||
| Q4 24 | 1.5% | 48.3% | ||
| Q3 24 | 3.1% | 42.7% | ||
| Q2 24 | 6.3% | 38.0% |
净利率
ELV
META
| Q1 26 | 1.1% | — | ||
| Q4 25 | 1.1% | 38.0% | ||
| Q3 25 | 2.3% | 5.3% | ||
| Q2 25 | 3.5% | 38.6% | ||
| Q1 25 | 4.5% | 39.3% | ||
| Q4 24 | 0.9% | 43.1% | ||
| Q3 24 | 2.3% | 38.7% | ||
| Q2 24 | 5.2% | 34.5% |
每股收益(稀释后)
ELV
META
| Q1 26 | $2.56 | — | ||
| Q4 25 | $2.56 | $8.87 | ||
| Q3 25 | $5.32 | $1.05 | ||
| Q2 25 | $7.72 | $7.14 | ||
| Q1 25 | $9.61 | $6.43 | ||
| Q4 24 | $1.88 | $7.96 | ||
| Q3 24 | $4.36 | $6.03 | ||
| Q2 24 | $9.85 | $5.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $9.5B | $81.6B |
| 总债务越低越好 | $31.9B | $58.7B |
| 股东权益账面价值 | $43.9B | $217.2B |
| 总资产 | $121.5B | $366.0B |
| 负债/权益比越低杠杆越低 | 0.73× | 0.27× |
8季度趋势,按日历期对齐
现金及短期投资
ELV
META
| Q1 26 | $9.5B | — | ||
| Q4 25 | $9.5B | $81.6B | ||
| Q3 25 | $8.7B | $44.4B | ||
| Q2 25 | $8.6B | $47.1B | ||
| Q1 25 | $7.5B | $70.2B | ||
| Q4 24 | $8.3B | $77.8B | ||
| Q3 24 | $7.9B | $70.9B | ||
| Q2 24 | $6.5B | $58.1B |
总债务
ELV
META
| Q1 26 | $31.9B | — | ||
| Q4 25 | $31.9B | $58.7B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $30.9B | $28.8B | ||
| Q3 24 | — | $28.8B | ||
| Q2 24 | — | — |
股东权益
ELV
META
| Q1 26 | $43.9B | — | ||
| Q4 25 | $43.9B | $217.2B | ||
| Q3 25 | $44.0B | $194.1B | ||
| Q2 25 | $43.7B | $195.1B | ||
| Q1 25 | $42.5B | $185.0B | ||
| Q4 24 | $41.3B | $182.6B | ||
| Q3 24 | $43.8B | $164.5B | ||
| Q2 24 | $42.2B | $156.8B |
总资产
ELV
META
| Q1 26 | $121.5B | — | ||
| Q4 25 | $121.5B | $366.0B | ||
| Q3 25 | $122.7B | $303.8B | ||
| Q2 25 | $121.9B | $294.7B | ||
| Q1 25 | $119.7B | $280.2B | ||
| Q4 24 | $116.9B | $276.1B | ||
| Q3 24 | $116.5B | $256.4B | ||
| Q2 24 | $113.0B | $230.2B |
负债/权益比
ELV
META
| Q1 26 | 0.73× | — | ||
| Q4 25 | 0.73× | 0.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.75× | 0.16× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $36.2B |
| 自由现金流经营现金流 - 资本支出 | — | $14.8B |
| 自由现金流率自由现金流/营收 | — | 24.8% |
| 资本支出强度资本支出/营收 | — | 35.7% |
| 现金转化率经营现金流/净利润 | — | 1.59× |
| 过去12个月自由现金流最近4个季度 | — | $46.1B |
8季度趋势,按日历期对齐
经营现金流
ELV
META
| Q1 26 | — | — | ||
| Q4 25 | $84.0M | $36.2B | ||
| Q3 25 | $1.1B | $30.0B | ||
| Q2 25 | $2.1B | $25.6B | ||
| Q1 25 | $1.0B | $24.0B | ||
| Q4 24 | $706.0M | $28.0B | ||
| Q3 24 | $2.7B | $24.7B | ||
| Q2 24 | $447.0M | $19.4B |
自由现金流
ELV
META
| Q1 26 | — | — | ||
| Q4 25 | $-209.0M | $14.8B | ||
| Q3 25 | $775.0M | $11.2B | ||
| Q2 25 | $1.8B | $9.0B | ||
| Q1 25 | $821.0M | $11.1B | ||
| Q4 24 | $384.0M | $13.6B | ||
| Q3 24 | $2.3B | $16.5B | ||
| Q2 24 | $124.0M | $11.2B |
自由现金流率
ELV
META
| Q1 26 | — | — | ||
| Q4 25 | -0.4% | 24.8% | ||
| Q3 25 | 1.5% | 21.8% | ||
| Q2 25 | 3.6% | 19.0% | ||
| Q1 25 | 1.7% | 26.2% | ||
| Q4 24 | 0.8% | 28.0% | ||
| Q3 24 | 5.2% | 40.6% | ||
| Q2 24 | 0.3% | 28.7% |
资本支出强度
ELV
META
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | 35.7% | ||
| Q3 25 | 0.7% | 36.7% | ||
| Q2 25 | 0.5% | 34.8% | ||
| Q1 25 | 0.4% | 30.6% | ||
| Q4 24 | 0.7% | 29.8% | ||
| Q3 24 | 0.7% | 20.3% | ||
| Q2 24 | 0.7% | 20.9% |
现金转化率
ELV
META
| Q1 26 | — | — | ||
| Q4 25 | 0.15× | 1.59× | ||
| Q3 25 | 0.95× | 11.07× | ||
| Q2 25 | 1.18× | 1.39× | ||
| Q1 25 | 0.47× | 1.44× | ||
| Q4 24 | 1.69× | 1.34× | ||
| Q3 24 | 2.63× | 1.58× | ||
| Q2 24 | 0.19× | 1.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELV
暂无分部数据
META
| Advertising | $58.1B | 97% |
| Reality Labs | $955.0M | 2% |
| Service Other | $801.0M | 1% |